We are live on ! Find out more
CCRN icon

Cross Country Healthcare

121 hedge funds and large institutions have $327M invested in Cross Country Healthcare in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 31

32% more capital invested

Capital invested by funds: $248M → $327M (+$79.2M)

2.62% less ownership

Funds ownership: 97.64%95.02% (-2.6%)

8% less funds holding

Funds holding: 131121 (-10)

37% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 19

Holders
121
Holders Change
-10
Holders Change %
-7.63%
% of All Funds
2.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
51
Reduced
31
Closed
19
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$44K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$50.3M +$768K +99,830 +2%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$24.4M +$351K +45,626 +2%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$22.9M -$1.54K -200 -0%
Vanguard Group
4
Vanguard Group
Pennsylvania
$22.8M +$1.22M +159,036 +7%
ACB
5
Aristotle Capital Boston
Massachusetts
$21.7M +$357K +46,349 +2%
SFM
6
Systematic Financial Management
New Jersey
$16M -$130K -16,849 -1%
JP Morgan Chase
7
JP Morgan Chase
New York
$15.7M -$386K -50,166 -3%
RA
8
Royce & Associates
New York
$14.6M +$2.63M +341,451 +28%
BSP
9
Benefit Street Partners
New York
$12.6M
State Street
10
State Street
Massachusetts
$12M -$197K -25,576 -2%
ICOM
11
Investment Counselors of Maryland
Maryland
$9.13M +$78.6K +10,207 +1%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$8.29M +$249K +32,322 +4%
Deutsche Bank
13
Deutsche Bank
Germany
$7.33M +$375K +48,675 +7%
TAM
14
Tocqueville Asset Management
New York
$5.19M +$2.31K +300 +0.1%
Invesco
15
Invesco
Georgia
$4.99M -$428K -55,558 -9%
Northern Trust
16
Northern Trust
Illinois
$4.64M +$136K +17,716 +4%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$4.42M +$27.6K +3,591 +0.8%
HA
18
Heartland Advisors
Wisconsin
$4.27M +$228K +29,625 +7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$4.25M +$230K +29,886 +7%
BCM
20
Bridgeway Capital Management
Texas
$3.76M +$1.23M +160,200 +67%
SEI Investments
21
SEI Investments
Pennsylvania
$3.59M +$92.6K +12,035 +3%
AQR Capital Management
22
AQR Capital Management
Connecticut
$3.46M -$1.05M -136,996 -27%
Principal Financial Group
23
Principal Financial Group
Iowa
$2.77M +$38K +4,932 +2%
Russell Investments Group
24
Russell Investments Group
United Kingdom
$2.47M +$1.8M +233,752 +784%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$2.44M +$1.66M +215,541 +481%

CCRN Hedge Fund Activity: Q2 2019 in Review

121 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q2 2019, worth a combined $327M — up 32% from $248M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CCRN and 12 opened new positions — a net loss of 7 holders — while 31 trimmed existing stakes and 51 added.

The largest buyer was Royce & Associates, adding an estimated $2.63M. The largest seller was Foundry Partners, exiting entirely with an estimated $2.58M sold.

  • 121 institutional investors held Cross Country Healthcare (CCRN) as of Q2 2019, down from 131 in Q1 2019.
  • Funds reported $327M of Cross Country Healthcare stock for Q2 2019, up 32% quarter-over-quarter.
  • 12 funds opened new Cross Country Healthcare positions in Q2 2019 and 19 closed out, a net change of -7 holders.
  • The largest Cross Country Healthcare buyer in Q2 2019 was Royce & Associates, an estimated $2.63M added.
  • The largest Cross Country Healthcare seller in Q2 2019 was Foundry Partners, an estimated $2.58M sold.

Based on aggregated 13F filings for Q2 2019.